Maple Leaf Foods' Food Safety Metrics, The Regulatory Future of Food Safety, and a Long-Term Chemical Safety Strategy at 2025 Food Safety Summit
Industry stakeholders from Maple Leaf Foods, PepsiCo, and regulatory agencies including FDA, USDA FSIS, and CDC shared insight's on the state of food safety at the 2025 Food Safety Summit in Rosemont, Il.
Regulators and industry leaders gathered at the 2025 Food Safety Summit to share updates, strategies, and data-driven insights aimed at reducing foodborne illness.
From an inside look at Maple Leaf Foods’ food safety metrics to the latest regulatory updates from key federal agencies, the 2025 Food Safety Summit closed Thursday with actionable insights food producers can take back to their plants.
Spir Marinakis with Maple Leaf Foods explained the company's Food Safety Incident Rate involves tracking six potential failure points at its plants.How Maple Leaf Foods tracks food safety
After a 2008 food safety failure at Maple Leaf Foods killed 23 people, the Canada-based food producer worked to ensure such an incident doesn’t happen again.
This started with a series of performance metrics to build back after the incident, but the protocols needed rethinking by the time Spir Marinakis, VP of Safety, Quality and Technical Services at Maple Leaf Foods, joined the team in 2016, she explained at the summit.
Starting the journey to develop a new plan, “I talked to the leadership of the organization, and the people in the plants who make our food, because in a manufacturing facility, they’re the ones that actually matter when we talk about food safety culture,” said Marinakis.
The result was a revised set of metrics including a Food Safety Incident Rate (FSIR), which involves a series of indicators to assess plants.
“The majority are indicators of failures in the system, failures of the company to do the right thing,” explained Marinakis. This goes against the typical emphasis on leading indicators that catch issues before they happen, but “if we just focus on leading indicators, there’s always a possibility that people are going to decide, ‘I’m not going to put that information in the system,’” she said.
The six failure points Maple Leaf Foods tracks include:
- Product recalls: “a recall is a complete failure of your system,” Marinakis said. Whether is leads to serious harm or not, a recall indicates multiple protective layers have broken down.
- Near misses: A near miss signals that protocols weren’t followed, even if the product is deemed low risk after a formal assessment. For example, a minor mislabeling may not trigger a recall, but it’s still a red flag to review processes in the facility.
- Pathogen positives: Maple Leaf Foods conducts extensive environmental swabbing in order to find positive test results in Zone 3, or before the contaminant hits food contact surfaces. “If it hits the food contact surface, which is what Zone 1 is, it’s a failure of the system,” Marinakis said.
- Regulatory non-compliance: While some might argue regulators are out of a company’s control, Marinakis disagrees. “You can proactively do that by building a better relationship,” she said.
- Repeat findings in internal audits: In Maple Leaf Foods’ internal audit program, “If they come in the second year and you haven’t dealt with it, it’s unacceptable,” said Marinakis.
- Food safety complaints: Measured as food safety complaints per million consumer units sold, this metric reflects real-world failures that escaped internal systems.
The company combines these failure points with a set of leading indicators including non-conformance, repeat issue analysis, internal audit findings, task observation trends, and more as it regularly assesses food safety at its plants
Ongoing change in food safety regulation
Kyle Diamantas (left) shared about a new FDA post-market chemical review plan, focusing on chemicals currently in the food supply.As leaders from the FDA, USDA-FSIS, and CDC shared their priorities and updates during a town hall at the summit, their remarks shared a common theme: change.
Kyle Diamantas, J.D., Acting Deputy Commissioner for Human Foods at FDA, outlined the agency’s modernization efforts following a 2022 external review. “That independent review revealed that the structure of FDA food portfolios sometimes hampered our ability to leverage our resources,” he said. In response, FDA launched the Human Foods Program (HFP) in 2024, unifying its food-related efforts under three pillars: preventing foodborne illness, ensuring chemical safety in food, and improving nutritional outcomes.
Diamantas emphasized the role of technology at FDA. “We recently hired FDA’s first ever Chief AI Officer,” he said, noting how generative AI can play a role in the administration’s modernization strategies. “We envision being able to leverage AI in many facets of what we do, including inspections, import alerts, recalls, and in our pre- and post-market work,” he said.
Also new at FDA, Diamantas shared about an upcoming post-market chemical review plan, opening for public comment later this month. “That plan will include the creation and rolling out of a modernized, evidence-based prioritization scheme for reviewing chemicals presently in the food supply,” he explained.
Denise Eblen, Administrator at the USDA FSIS acknowledged the ongoing changes at USDA and the wider federal workforce.
“USDA is still in transition, and we’ll keep you informed as we learn any more about changes that might impact FSIS,” Eblen said. “FSIS’ frontline positions are considered public safety positions, and so we continue to hire the workforce necessary to meet our obligations to ensure a safe and abundant food supply.”
Eblen noted about FSIS’s March 17 directive to extend line speed waivers previously granted to young chicken and swine slaughter establishments. The extension allows these plants to maintain higher line speeds while rulemaking is underway.
“I do want to clarify that the extension is limited to the young chicken and swine establishments that already have line speed waivers, and that we are not going to issue any new line speed waivers at this time,” Eblen said.
In response to recent listeria outbreaks, FSIS is expanding testing to all samples of ready-to-eat product, and prioritizing food safety assessments in ready-to-eat meat and poultry plants. “These measures are aimed at strengthening the agency’s oversight of food processing facilities as we inspect and ensure food safety,” said Eblen.
On salmonella control, FSIS has delayed the start of sampling and testing for not-ready-to-eat breaded and stuffed chicken products until November 3, 2025, allowing more time for industry and agency preparation.
Attending virtually, Dr. Megin Nichols, Director of CDC’s Division of Foodborne, Waterborne, and Environmental Diseases, emphasized change as she takes the helm following her predecessor’s retirement. “We are reexamining all of our efforts under my leadership, with a focus on public health impact and our return on investment,” Nichols said.
Nichols emphasized CDC’s role in aggregating outbreak data and supporting local health agencies. She noted that CDC invested $22 million last fiscal year to fund about 400 food safety staff across 56 jurisdictions.
She also highlighted recent modernization of PulseNet, CDC’s laboratory network that detects clusters of foodborne illness. The updates have allowed CDC to catch foodborne outbreaks and clusters of illness more efficiently, she said, estimating that it “it saves about $70 for every $1 that’s invested.”
Joseph Starr (center left) noted how collateral effects of regulatory changes in food chemicals can impact supply chains, cost, and food security.A perspective on long-term food chemical safety strategy from PepsiCo
What should a company’s long-term strategy be to ensure ongoing chemical safety in food processing?
Joseph Starr, FSQA Manager, Global Compliance at PepsiCo, shared his perspective at the summit Thursday.
“Robust hazard analysis, robust risk assessments; having those capabilities in-house can be important, especially in a time of rapid change,” said Starr. “Engage your relevant trade association, because these conversations are happening at the industry level. So don’t do too much in a vacuum; be a part of the conversation.
“Advocate for science for your ingredients and products. Testing is a tool to measure compliance, and it’s also an advocacy tool, because for us to be able to conduct robust science, a sample size of two test results is not good enough, right? You want a statistically valid sample to really make a point.
“I think we also need to be advocating for the knock-off impacts of these regulatory changes in the chemical space: Supply chains need time to change, so we also need transition times as an industry. What is that impact going to be to food cost in a time of rising inflation?
“Then the topic on a global scale, what about food security? That’s entered the conversation for more regulators, particularly in Europe, which has slowed down some of the rapid changes that they were making because they started to see some supply chains being disrupted, and they recognized that food security should be a part of this topic when making policy decisions.”
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.